Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)

Revolution Medicines has reported Tax Provisions over the past 4 years, most recently at -$15000.0 for Q4 2024.

  • Quarterly results put Tax Provisions at -$15000.0 for Q4 2024, down 100.36% from a year ago — trailing twelve months through Dec 2024 was -$15000.0 (down 104.63% YoY), and the annual figure for FY2024 was -$15000.0, down 104.63%.
  • Tax Provisions for Q4 2024 was -$15000.0 at Revolution Medicines, down from $4.2 million in the prior quarter.
  • Over the last five years, Tax Provisions for RVMD hit a ceiling of $4.2 million in Q4 2023 and a floor of -$3.9 million in Q3 2023.
  • Median Tax Provisions over the past 4 years was -$36500.0 (2020), compared with a mean of -$7750.0.
  • Peak annual rise in Tax Provisions hit 1311.11% in 2023, while the deepest fall reached 1202.02% in 2023.
  • Revolution Medicines' Tax Provisions stood at $362000.0 in 2020, then dropped by 17.96% to $297000.0 in 2022, then soared by 1311.11% to $4.2 million in 2023, then crashed by 100.36% to -$15000.0 in 2024.
  • The last three reported values for Tax Provisions were -$15000.0 (Q4 2024), $4.2 million (Q4 2023), and -$3.9 million (Q3 2023) per Business Quant data.